Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Inflammation in Depression (DECAMERONE)
NCT00951132Phase 2Withdrawn
- Start
- Sep 2009
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in major depressive disorder (MDD), atherosclerosis. Planned start Sep 2009; status: withdrawn.
02
Drugs
rosuvastatin
03
Conditions
major depressive disorder (MDD)atherosclerosis
Beyond the preview
Go deeper on NCT00951132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00951132.